• Home
  • NEW DAY MEDICINE
  • 4 (54) 2023
  • 35 -4 (54) 2023 — Musakhodjaeva D.A., Faizullaeva N.J. — THE ROLE OF THE IMMUNE SYSTEM IN THE FORMATION OF ENDOTHELIAL DYSFUNCTION IN IMPAIRED UTERINE-PLACENTAL-FETAL CIRCULATION

35 -4 (54) 2023 — Musakhodjaeva D.A., Faizullaeva N.J. — THE ROLE OF THE IMMUNE SYSTEM IN THE FORMATION OF ENDOTHELIAL DYSFUNCTION IN IMPAIRED UTERINE-PLACENTAL-FETAL CIRCULATION

THE ROLE OF THE IMMUNE SYSTEM IN THE FORMATION OF ENDOTHELIAL DYSFUNCTION IN IMPAIRED UTERINE-PLACENTAL-FETAL CIRCULATION

Musakhodjaeva D.A., Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan. Center for the development of professional qualifications of medical workers Uzbekistan. Tashkent Medical Academy

Faizullaeva N.J., Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan. Center for the development of professional qualifications of medical workers Uzbekistan. Tashkent Medical Academy

Eshimbetova G.Z., Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan. Center for the development of professional qualifications of medical workers Uzbekistan. Tashkent Medical Academy

Jumaeva D.M., Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan. Center for the development of professional qualifications of medical workers Uzbekistan. Tashkent Medical Academy

Sadykova H.Z., Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan. Center for the development of professional qualifications of medical workers Uzbekistan. Tashkent Medical Academy

Muzafarova S.A., Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan. Center for the development of professional qualifications of medical workers .Uzbekistan Tashkent Medical Academy

An A.V., Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan. Center for the development of professional qualifications of medical workers Uzbekistan. Tashkent Medical Academy

Azizova Z.Sh., Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan. Center for the development of professional qualifications of medical workers Uzbekistan. Tashkent Medical Academy

Rustamova N.B. Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan. Center for the development of professional qualifications of medical workers Uzbekistan. Tashkent Medical Academy

Resume

This article reviews the importance of uteroplacental circulation in the process of fetal growth and development during pregnancy. The mechanisms of epithelial dysfunction formation in impaired uteroplacental-fetal circulation are reviewed and the significance of immunological and endothelial biomarkers is reflected. Disturbances of uterine-placental blood flow lead to such pregnancy complications as preeclampsia, fetal growth retardation, hypoxia up to fatal outcome. IPC regulation is vital for maternal and fetal well-being.

Key words: endothelial dysfunction, endothelium, fetal growth retardation, uteroplacental blood flow, immunity.

First page

177

Last page

185

For citation: Musakhodjaeva D.A, Faizullaeva N.J, Eshimbetova G.Z, Jumaeva D.M, Sadykova H.Z., Muzafarova S.A., An A.V., Azizova Z.Sh., Rustamova N. B. – THE ROLE OF THE IMMUNE SYSTEM IN THE FORMATION OF ENDOTHELIAL DYSFUNCTION IN IMPAIRED UTERINE-PLACENTAL-FETAL CIRCULATION //New Day in Medicine 4(54)2023 177-185 https://goo.su/nXF0mpS

LIST OF REFERENCES:

  1. Агафонова А.В. Васильев В.В., Рогозина В. Морфологическая характеристика плаценты при инфекционном поражении // Практическая медицина. 2021;19(1):8-14.
  2. Бывальцев В.А., И.А.Степанов, Н.А.Тетюшкин Роль цитокинов воспаления в формировании и разрыве артериовенозных мальформаций головного мозга // Патологическая физиология и экспериментальная терапия. 2018;62(4):185-194.
  3. Доронина, П.Ю. Современный взгляд на проблему фетоплацентарной недостаточности // Аллея науки. 2018;7(11(27):143–155.
  4. Карапетян А.О., Баева М.О., Баев О.Р. Роль внеклеточной ДНК плода в прогнозировании больших акушерских синдромов. // Акушерство и гинекология. 2018;(4):10-5. https://doi.org/10.18565/ aig.2018.4.10-15
  5. Круглякова М.В. Характеристика цитокинового профиля при физиологической и осложненной беременности // Культура, наука, образование: проблемы и перспективы: Материалы IХ Международной научно-практической конференции, Нижневартовск, 10 ноября 2021 года Нижневартовск: Нижневартовский государственный университет, 2021; 548-555.
  6. Кузнецова И.В., Гаврилова Е.А. Клинический опыт коррекции эндотелиальной дисфункции на этапе подготовки к беременности больных синдромом поликистозных яичников. // Эффективная фармакотерапия. 2020;16(28):36-40.
  7. Миронов А.В. Роль дисфункции эндотелия в развитии материнской, перинатальной и детской заболеваемости // Акушерство, гинекология и репродукция. 2020;14(5):600-610.
  8. Пестрикова Т.Ю. Плацентарная недостаточность как базовая патология осложнений и исходов гестационного периода // Российский вестник акушера-гинеколога. 2020;20(1):5-15.
  9. Тастанова Г., Юнусов С., Шаниеваа С. Современный взгляд на проблему фетоплацентарной недостаточности // Журнал” Медицина и инновации”. 2022;3:304-312.
  10. Трошина, Е.А. Роль цитокинов в процессах адаптивной интеграции иммунных и нейроэндокринных реакций организма // Проблемы эндокринологии. 2021;67(2):4-9.
  11. Шульженко А.Е. Противовирусный иммунитет репродуктивного тракта: от изучения системы до коррекции работы // Русский медицинский журнал. Медицинское обозрение. – 2019;3(12):14-19.
  12. Brewster LM, Garcia VP, Levy MV, et al. Endothelin-1-induced endothelial microvesicles impair endothelial cell function. // J Appl Physiol. 2020 Jun 1;128(6):1497-1505.
  13. Chang X, Yao J, He Q, et al. Exosomes from Women with Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble FmsLike Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells. // Hypertension. 2018 Dec; 72(6):1381-1390.
  14. Coban U, Takmaz T, Unyeli OD, Ozdemir S. Adverse Outcomes of Preeclampsia in Previous and Subsequent Pregnancies and the Risk of Recurrence. // Sisli Etfal Hastan Tip Bul. 2021 Sep 24; 55(3): 426-431.
  15. de Moreuil C, Alavi Z, Pasquier E. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage. // Br J Clin Pharmacol. 2020 Jan; 86(1): 39-49.
  16. Erez O, Romero R, Jung E, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022 Feb; 226(2S): 786-803.
  17. Filipek A, Jurewicz E. Preeklampsja – choroba kobiet w ciąży [Preeclampsia – a disease of pregnant women]. // Postepy Biochem. 2018 Dec 29; 64(4): 232-229.
  18. Frishman M, Radin M, Schreiber K. Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysis. // Curr Opin Obstet Gynecol. 2020 Oct; 32(5): 351-358.
  19. Gabryel B, Bontor K, Jarząbek K, et al. Sulodexide up-regulates glutathione S-transferase P1 by enhancing Nrf2 expression and translocation in human umbilical vein endothelial cells injured by oxygen glucose deprivation. // Arch Med Sci. 2019 Feb 11; 16(4): 957-963.
  20. Gamble D.T., Brikinns B., Myint P.K., et al. Hypertensive disorders of pregnancy and subsequent cardiovascular disease: Current national and international guidelines and the need for future research. // Front. Cardiovasc. Med. 2019; 6: 55.

file

download